Dr Roy Drucker

MA, MB, BChir, MRCS, LRCP, FFPM, MSI

Chief Executive Officer

Dr Roy Drucker is the founder Director and Chief Executive Officer of Infinitus Clinical Research. Dr. Drucker began his career with the European R&D arm of Sterling Drug Inc. as a medical advisor and was later promoted to be responsible for clinical pharmacology, drug metabolism and bioanalysis for all of Europe. In 1986 he moved to the Upjohn Company (USA), subsequently Pharmacia & Upjohn, Inc., where he held a range of international responsibilities. His positions there included Director, Marketing with responsibility for worldwide marketing of cardiovascular products; Executive Director, European Community Affairs and Business Systems; and Vice-President, Drug Development with global responsibility, in multiple therapeutic areas, for clinical drug development and medical support for marketed products. In 1996 he joined Technomark in the UK as General Manager and lead services to the healthcare and bioscience industries, with particular emphasis on the pharmaceutical, biotechnology and contract research organization sectors. A graduate of Cambridge University, the Harvard School of Advanced Management, a member of the Securities Institute and an FSA Registered Securities Representative, Roy has been based in Belgium, the United States, and most recently the UK, India, and China. He has conducted business in Japan, North America, Western Europe, India, China, and Hong Kong.

Currently, Roy holds several global appointments, including Chief Medical Officer of Technomark Group USA and Chief Medical Officer of a bio-informatics company in the UK. He also serves as a board member for Technomark Group USA as well as board member of several other life science companies.